BATM Advanced Communications Ltd - Israel-based networking and medical technology company - says it has developed a new test for the rapid and comprehensive diagnosis of tuberculosis. Test takes two hours instead of several days with current methods. Clinical trials to start in second half of this year, fully funded by UN's Stop TB Partnership. Expects sales to begin next year.
Current stock price: 98.40 pence
Year-to-date change: up 5.8%
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


IN BRIEF: BATM Advanced Annual Revenue To Beat Market Estimates


LONDON MARKET MIDDAY: Stocks Higher As Mood Lifts And Oil Prices Climb


UK WINNERS & LOSERS SUMMARY: BATM Up On Covid-19 Antibody Test Launch


BATM Shares Rise On Launch Of New Covid-19 Antibody Test


UK TRADING UPDATE SUMMARY: BATM Gets EUR29 Million Ventilator Order


BATM Advance Communications Shares Jump On Covid-19 Home Testing Kit


UK WINNERS & LOSERS SUMMARY: BATM In Covid-19 Home Test Collaboration


BATM Advanced Communications Outlook Strong After "Good" Year